International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding

Author(s): Chan Debora Schotik

Issue: Mar/Apr 2001 - Compounding for Animals
View All Articles in Issue

Page(s): 97-100

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 1

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 2

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 3

Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Page 4

Download in electronic PDF format for $75

Abstract: Regulations for the use of bulk drugs in animals are unclear. In this article, the author focuses on US food and drug regulations, use of bulk drugs to compound for humans and animals, US Food and Drug Administration regulations governing the use of bulk drugs, and regulatory actions. Tables provide a list of proposed bulk drugs suitable for use in compounding for humans, drug products not to be used in compounding and drugs prohibited for extralabel use in food-producing animals.

Related Keywords: food and drug regulations, medications for animals

Related Categories: LEGAL, VETERINARY, FDA

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Chan Debora Schotik	Mar/Apr 2001 Pg. 97-100
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
When to Compound Medications for Veterinary Patients Forsythe Lauren Eichstadt	Jan/Feb 2017 Pg. 19-21
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)	Nov/Dec 2016 Pg. 457-458
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Harrington Catherine A, Cauffield Jacintha	May/Jun 2005 Pg. 201-205
Regulatory and Operational Issues of Founding a Compounding Pharmacy Smith Lisa K	Nov/Dec 2002 Pg. 434-437
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Allen Loyd V Jr	Nov/Dec 2006 Pg. 446-448
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Allen Loyd V Jr	Nov/Dec 2023 Pg. 474-481
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Allen Loyd V Jr, Ashworth Lisa D	Jan/Feb 2005 Pg. 44-46
Return to Top